Novartis RSI is the most oversold it has been in 9 years
It now sits on a strong support with a range of just 2 dollars below current levels
Fib retracement of 1.618 takes this to 74 dollars before the turnaround
All of pharma has taken a hit over the last 4 weeks without real justification.
I believe all pop up after they announce earnings throughout the week
NVS Novartis owns or makes a slew of pharmacopial needs for a variety of medical needs.
Little dip during recent pullback.
Watching Friday ads, all brand names no companies. All Novartis or made for another company by Novartis.
The price got out of its ranging bound. The lagging span broke the Kijun and had just bounced on the range rectangle before. We may expect the price to lateralize a bit before the earnings and then, if they are positive, to see an uptrend that would make it reach the higher part of the cloud. A retracement after benefits are taken would provide a good entry point...